Rubius Therapeutics, Inc. (RUBY) Financial Statements (2023 and Earlier)

Company Profile

Business Address 399 BINNEY STREET, SUITE 300
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments225,848176,287283,287404,051
Cash and cash equivalents225,84891,16591,898307,064
Short-term investments 85,122191,38996,987
Restricted cash and investments100100 622
Other undisclosed current assets3,8755,1245,9799,737
Total current assets:229,823181,511289,266414,410
Noncurrent Assets
Operating lease, right-of-use asset35,09540,44746,559
Property, plant and equipment51,53053,95256,92462,796
Restricted cash and investments1,5731,5731,7351,735
Other noncurrent assets 311357168
Total noncurrent assets:88,19896,283105,57564,699
TOTAL ASSETS:318,021277,794394,841479,109
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities21,34714,56412,7587,886
Accounts payable11,5725,4787,1787,886
Accrued liabilities670554322 
Employee-related liabilities7,4518,1245,045 
Interest and dividends payable1,654408213 
Debt  10,540 
Other undisclosed current liabilities13,31213,27610,46212,118
Total current liabilities:34,65927,84033,76020,004
Noncurrent Liabilities
Long-term debt and lease obligation104,445107,70686,46365,788
Long-term debt, excluding current maturities76,15474,94449,59624,347
Capital lease obligations41,441
Operating lease, liability28,29132,76236,867
Liabilities, other than long-term debt135688405143
Deferred rent credit   143
Other liabilities135688405 
Other undisclosed noncurrent liabilities   166
Total noncurrent liabilities:104,580108,39486,86866,097
Total liabilities:139,239136,234120,62886,101
Stockholders' equity
Stockholders' equity attributable to parent178,782141,560274,213393,008
Common stock90818079
Additional paid in capital855,710621,946586,798543,040
Accumulated other comprehensive income (loss) 475(29)
Accumulated deficit(677,018)(480,471)(312,740)(150,082)
Total stockholders' equity:178,782141,560274,213393,008
TOTAL LIABILITIES AND EQUITY:318,021277,794394,841479,109

Income Statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues
(Sublease Income)
7191,017908 
Gross profit:7191,017908 
Operating expenses(194,616)(166,448)(169,601)(91,663)
Other undisclosed operating loss(719)(1,017)(908) 
Operating loss:(194,616)(166,448)(169,601)(91,663)
Nonoperating income (expense)(1,931)(1,283)6,1432,468
Investment income, nonoperating911,7607,994329
Other nonoperating income4,4121,142739 
Interest and debt expense(6,434)(4,185)(2,590)(464)
Loss before gain (loss) on sale of properties:(202,981)(171,916)(166,048)(89,659)
Other undisclosed net income6,4344,1852,590464
Net loss available to common stockholders, diluted:(196,547)(167,731)(163,458)(89,195)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(196,547)(167,731)(163,458)(89,195)
Comprehensive loss:(196,547)(167,731)(163,458)(89,195)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(4)(71)104(29)
Comprehensive loss, net of tax, attributable to parent:(196,551)(167,802)(163,354)(89,224)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: